Supriya Lifescience News and Updates

Name: Latest research reports of Supriya Lifescience Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Supriya Lifescience Ltd.
Rating: 3
Author: ICICI Securities Limited

Keep track of all breaking news on Supriya Lifescience from all sources in a single place.

Load latest

Supriya Lifescience Ltd.

16 Dec 2021

744.00

-0.28%

Supriya Lifescience : IPO

IPO Note: Supriya Lifescience Ltd.

ICICI Securities Limited

Supriya has been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India, contributing to 45-50% and 60-65%, respectively, of the API exports from India, between FY17 and FY21. SLL is among the largest exporters of Salbutamol Sulphate in India contributing to...

Supriya Lifescience Ltd. is trading below its 30 day SMA of 762.8

Supriya Lifescience Ltd.

15 Dec 2021

744.00

-0.28%

Pre-IPO Analyst Meet for Supriya Lifescience

Pre-IPO Conference Call with Supriya Lifescience. Listen to the full transcript.

Supriya Lifescience Ltd.

15 Dec 2021

744.00

-0.28%

Supriya Lifescience Ltd

IPO Subscribe: Supriya Lifescience Ltd.

Angel Broking

Supriya Lifescience Limited was incorporated in March 2008 by Satish Waman Wagh. Company is one of the key Indian manufacturers and suppliers of active pharmaceutical ingredients (APIs). Supriya Lifescience Limited focus on research and development along with this company focus is on diverse therapeutic areas and niche products. Company has niche product offerings of 38

Supriya Lifescience Ltd. is trading above its 200 day SMA of 698.2

Supriya Lifescience Ltd.

15 Dec 2021

744.00

-0.28%

SUPRIYA LIFESCIENCE LTD.

IPO Note: Supriya Lifescience Ltd.

Ventura

IPO NOTE

Supriya Lifescience Ltd. is trading below its 30 day SMA of 762.8

Supriya Lifescience Ltd.

15 Dec 2021

744.00

-0.28%

Supriya Lifescience Ltd. IPO Note

IPO Note: Supriya Lifescience Ltd.

Ashika Research

Public issue of 2,55,47,445 Equity shares of Face value Total Public 2 each, (Comprising of fresh issue of 72,99,270 Equity Shares* (Rs. 200 cr.) and Offer for Sale of 1,82,48,175 Equity Shares* (Rs. 500 cr.) by Selling Shareholder)....

Supriya Lifescience Ltd. is trading above its 200 day SMA of 698.2

VOTE: Is Supriya Lifescience Ltd. worth buying?

113 Votes:

Buy 86.73%

Sell 6.19%

Hold 7.08%

RESEARCH REPORTS

Accumulate SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf

33.78% Gain from 52W Low

Supriya Lifescience News and Updates

Keep track of all breaking news on Supriya Lifescience from all sources in a single place.